Human Lck Antibody, R&D Systems™

Lck

Monoclonal

LYOPH

Western Blot 0.2 ug/mL, Simple Western 2 ug/mL, Intracellular Staining by Flow Cytometry 2.5 ug/10^6 cells, Immunocytochemistry 8-25 ug/mL, CyTOF-ready

P06239

LCK

E. coli-derived recombinant human Lck Met1-Val66 Accession # P06239

100 μg

Primary

Detects human Lck in direct ELISAs. In direct ELISAs, no cross-reactivity with recombinant rat Lck is observed.

Human

Purified

Western Blot, Flow Cytometry, Immunocytochemistry, CyTOF

693010

Unconjugated

Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. with No Preservative

EC 2.7.10, EC 2.7.10.2, Hck-3, Lcktkr, Leukocyte C-terminal Src kinase, LSK, LSTRA, Lymphocyte cell-specific protein-tyrosine kinase, lymphocyte-specific protein tyrosine kinase, p56(LSTRA) protein-tyrosine kinase, p56lck, p56-LCK, pp58lck, Protein YT16, Proto-oncogene Lck, proto-oncogene tyrosine-protein kinase LCK, T cell-specific protein-tyrosine kinase, T-lymphocyte specific protein tyrosine kinase p56lck, tyrosine-protein kinase Lck, YT16

Mouse

Protein A or G purified from hybridoma culture supernatant

RUO

3932

Sterile PBS to a final concentration of 0.5 mg/mL.

Use a manual defrost freezer and avoid repeated freeze-thaw cycles.12 months from date of receipt, -20 to -70 degreesC as supplied. 1 month, 2 to 8 degreesC under sterile conditions after reconstitution. 6 months, -20 to -70 degreesC under sterile conditions after reconstitution.

IgG2a